Research of Leber Congenital Amaurosis has been linked to Amaurosis, Blind Vision, Retinitis Pigmentosa, Retinal Degeneration, Retinal Diseases. The study of Leber Congenital Amaurosis has been mentioned in research publications which can be found using our bioinformatics tool below. Researched pathways related to Leber Congenital Amaurosis include Localization, Pathogenesis, Phototransduction, Transport, Cell Death. These pathways complement our catalog of research reagents for the study of Leber Congenital Amaurosis including antibodies and ELISA kits against RPE65, GUCY2D, CLTA, PTPRC, RETINAL DYSTROPHY.
Leber Congenital Amaurosis Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Leber Congenital Amaurosis below!
For more information on how to use Laverne, please read the How to Guide.
We have 1832 products for the study of Leber Congenital Amaurosis that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence from our catalog of antibodies and ELISA kits.
Leber Congenital Amaurosis is also known as leber congenital amaurosis, lca, leber's congenital tapetoretinal degeneration, leber's congenital tapetoretinal dysplasia, hereditary epithelial dysplasia of retina, congenital absence of the rods and cones, congenital amaurosis of retinal origin, dysgenesis neuroepithelialis retinae, amaurosis congenita of leber, type 1, heredoretinopathia congenitalis, amaurosis congenita of leber i, leber's amaurosis (disorder), amaurosis congenita of leber, amaurosis, leber congenital, lebers congenital amaurosis, hereditary retinal aplasia, intraepithelial neoplasia, neonatal hemochromatosis, retinal aplasia, leber's disease, amaurosis, crb.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.